Fundraising of US$ 5 million.
We are pleased to invite you to MedCu Technologies’ Investor Webinar, where we’ll share how MedCu’s copper-based wound care solutions are redefining the standard of care in a $35 billion global market.
Highlights:
- The first and only copper wound dressing with FDA and CE clearance worldwide
- Natural element with both antimicrobial + healing properties
- Proven superior healing outcomes vs. standard of care at 15% of the cost (RCT 2025)
- Growing global commercialization across 50+ countries
- Selected for the 2025 MedTech Innovator Accelerator, the world’s leading medtech program (finalist of Medtech’s Grand Prize)
Main use of Proceeds:
- Support growth – Expand sales force and move to full commercial expansion in the US and globally.
- Clinical validation – RCT to support enhanced wound healing regulation and marketing claims.
- Second family of products (Copper 3D foam dressings) – Finalize FDA & CE registrations.
- Readiness for a strategic transaction.
Join Danny Lustiger, Co-founder & CEO, and the MedCu leadership team to hear about the copper revolution and the MedCu growth strategy, upcoming clinical milestones, and current fundraising opportunity.
Background:
Borkow, G.; Melamed, E. The Journey of Copper-Impregnated Dressings in Wound Healing: From a Medical Hypothesis to Clinical Practice. Biomedicines 2025, 13, 562. https://doi.org/10.3390/ biomedicines13030562. Read the article HERE.
MedCu – leading the Copper revolution: Watch the video HERE (1 minut)
Date: Wednesday, 3 December
Time: 14:00 CET (Online, 30 minutes)
Registration (Zoom): HERE.
We look forward to sharing how MedCu is creating the new standard of care in wound healing.